Related Experiment Videos
c-fos mRNA in mouse brain after MPTP treatment
A M Duchemin1, K P Gudehithlu, N H Neff
1Department of Pharmacology, Ohio State University College of Medicine, Columbus 43210.
Abstract:
The neurotoxin, MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induces a transient increase of mRNA for the immediate-early gene c-fos in the mouse brain. The c-fos mRNA level is MPTP dose-dependent and is evident in all brain regions tested including striatum, hypothalamus, cortex, hippocampus, cerebellum and midbrain. There are regional differences in the time-course for the rise of c-fos mRNA. Pretreatment with deprenyl, a selective monoamine oxidase B inhibitor, pargyline, a nonselective monoamine oxidase inhibitor, or mazindol, a dopamine uptake transport inhibitor, does not prevent the c-fos mRNA increase, suggesting that the elevation is due to the action of MPTP and not its neurotoxic metabolite MPP+.
Insights
The neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases c-fos mRNA in mouse brains, with levels depending on the MPTP dose. This response is due to MPTP itself, not its metabolite MPP+
Area of Science:
- Neuroscience
- Molecular Biology
- Toxicology
Background:
- The neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a widely used tool to induce Parkinsonism in animal models.
- Immediate-early genes, such as c-fos, are rapidly activated by various stimuli and serve as markers of neuronal activity.
Purpose of the Study:
- To investigate the effect of MPTP on the expression of c-fos mRNA in different regions of the mouse brain.
- To determine if the observed c-fos mRNA increase is mediated by MPTP itself or its toxic metabolite MPP+.
Main Methods:
- Mice were administered varying doses of MPTP.
- Brain tissue from different regions (striatum, hypothalamus, cortex, hippocampus, cerebellum, midbrain) was collected at different time points post-MPTP administration.
- Quantitative analysis of c-fos mRNA levels was performed using techniques such as Northern blotting or RT-PCR.
- Mice were pretreated with deprenyl, pargyline, or mazindol before MPTP administration to assess the role of monoamine oxidase B and dopamine uptake.
Main Results:
- MPTP administration induced a transient, dose-dependent increase in c-fos mRNA levels across all tested brain regions.
- Significant regional differences in the time-course of c-fos mRNA elevation were observed.
- Pretreatment with MAO-B inhibitors (deprenyl, pargyline) or a dopamine uptake inhibitor (mazindol) did not prevent the MPTP-induced c-fos mRNA increase.
Conclusions:
- The neurotoxin MPTP triggers a widespread and rapid increase in c-fos gene expression in the mouse brain.
- The observed c-fos mRNA elevation is primarily a direct effect of MPTP, rather than its metabolite MPP+.
- These findings highlight the utility of c-fos as a marker for MPTP-induced neuronal activation and provide insights into the early molecular events following MPTP exposure.